학술논문
Intravenous Tirofiban Versus Alteplase Before Endovascular Treatment in Acute Ischemic Stroke: A Pooled Analysis of the DEVT and RESCUE BT Trials
Document Type
Academic Journal
Author
Sang, Hongfei; Cao, Zhihua; Du, Jie; Nguyen, Thanh N.; Saver, Jeffrey L.; Mao, An; Nogueira, Raul G.; Tao, Zhaojun; Zhou, Simin; Han, Qin; Sun, Dong; Lei, Bo; Liu, Shudong; Zeng, Guoyong; Yin, Congguo; Xie, Dongjing; Luo, Weidong; Jin, Zhenglong; Qiu, Zhongming; Yang, Qingwu; Wu, Deping; Shi, Zhonghua; Huang, Wenguo; Liu, Wenhua; Qiu, Tao; Zhou, Peiyang; Wang, Li; Fu, Xinmin; Yang, Shiquan; Zhang, Shuai; Zhou, Zhiming; Wang, Yan; Luo, Jun; Bai, Yongjie; Zhang, Min; Wu, Youlin; Wan, Yue; Wen, Changming; Wen, Hongbin; Ling, Wentong; Chen, Zhuo.; Peng, Miao; Ai, Zhibing; Guo, Fuqiang; Guo, Jing; Guan, Haitao; Wang, Zhiyi; Liu, Yong; Pu, Jie; Wang, Zhen; Yang, Qingwu; Liu, Wenhua; Li, Huagang; Huang, Wenguo; Zhang, Min; Zhou, Peiyang; Zhou, Zhiming; Song, Bo; Wen, Changming; Yuan, Guangxiong; Luo, Jun; Zheng, Chong; Wang, Shouchun; Wang, Tao; Qi, Li; Wan, Yue; Wu, Youlin; Peng, Daizhou; Chang, Mingze; Shi, Zhonghua; Jin, Ying; Huang, Chuming; Liu, Tianzhu; Zhao, Wenlong; Wang, Jian; Wang, Li; Liu, Shugai; Luo, Shiwei; Pu, Jie; Chen, Shengli; Sun, Yaxuan; Jiang, Shunfu; Wei, Liping; Fu, Xinmin; Bai, Yongjie; Yang, Shunyu; Hu, Wei; Zhang, Guling; Pan, Chengde; Zhang, Shuai; Wang, Yan; Cao, Wenfeng; Yang, Shiquan; Zhang, Jun; Guo, Fuqiang; Wen, Hongbin; Zhang, Jinhua; Lu, Mengjie
Source
Stroke. Apr 01, 2024 55(4):856-865
Subject
Language
English
ISSN
0039-2499
Abstract
BACKGROUND:: The present study aimed to evaluate the efficacy and safety of intravenous tirofiban versus alteplase before endovascular treatment (EVT) in acute ischemic stroke patients with intracranial large vessel occlusion. METHODS:: This was a post hoc analysis using data from 2 multicenter, randomized trials: the DEVT trial (Direct Endovascular Treatment for Large Vessel Occlusion Stroke) from May 2018 to May 2020 and the RESCUE BT trial (Intravenous Tirofiban Before Endovascular Thrombectomy for Acute Ischemic Stroke) from October 2018 to October 2021. Patients with acute intracranial large vessel occlusion within 4.5 hours from last known well were dichotomized into 2 groups: tirofiban plus EVT versus alteplase bridging with EVT. The primary outcome was functional independence (modified Rankin Scale score of 0–2) at 90 days. Safety outcomes included symptomatic intracranial hemorrhage and 3-month mortality. Multivariable logistic regression (adjusting for baseline systolic blood pressure, occlusion site, onset-to-puncture time, anesthesia, and first choice of EVT) and propensity score overlap weighting (balance in demographic covariates, stroke characteristics, and initial management between groups) were performed. RESULTS:: One-hundred and eighteen alteplase-treated patients in the DEVT trial and 98 tirofiban-treated patients in the RESCUE BT trial were included (median age, 70 years; 115 [53.2%] men). The rate of functional independence was 60.2% in the tirofiban group compared with 46.6% in the alteplase group (adjusted odds ratio, 1.25 [95% CI, 0.60–2.63]). Compared with alteplase, tirofiban was not associated with increased risk of symptomatic intracranial hemorrhage (6.8% versus 9.2%; P=0.51) and mortality (17.8% versus 19.4%; P=0.76). The propensity score overlap weighting analyses showed consistent outcomes. CONCLUSIONS:: Among patients with intracranial large vessel occlusion within 4.5 hours of onset, tirofiban plus EVT was comparable to alteplase bridging with EVT regarding the efficacy and safety outcomes. These findings should be interpreted as preliminary and require confirmation in a randomized trial. REGISTRATION:: URL: https://www.chictr.org.cn; Unique identifiers: ChiCTR-IOR-17013568 and ChiCTR-INR-17014167.